Cargando…

Sustained weight loss after duodenal–jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m(2): A retrospective cohort study

Previous data from short term studies have shown an efficacy of the duodenal‐jejunal bypass liner (DJBL) for weight loss. However, less data is available regarding weight change after device removal and possible predictors for weight loss. This is a retrospective chart review of all patients who had...

Descripción completa

Detalles Bibliográficos
Autores principales: Boonchaya‐anant, Patchaya, Bueter, Marco, Gubler, Christoph, Gerber, Philipp A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078000/
https://www.ncbi.nlm.nih.gov/pubmed/36239531
http://dx.doi.org/10.1111/cob.12561
_version_ 1785020420329570304
author Boonchaya‐anant, Patchaya
Bueter, Marco
Gubler, Christoph
Gerber, Philipp A.
author_facet Boonchaya‐anant, Patchaya
Bueter, Marco
Gubler, Christoph
Gerber, Philipp A.
author_sort Boonchaya‐anant, Patchaya
collection PubMed
description Previous data from short term studies have shown an efficacy of the duodenal‐jejunal bypass liner (DJBL) for weight loss. However, less data is available regarding weight change after device removal and possible predictors for weight loss. This is a retrospective chart review of all patients who had DJBL inserted at the University Hospital Zurich between December 2012 and June 2015. A total of 27 patients had DJBL insertion. The median BMI at baseline was 38.5 (34.0–42.2) kg/m(2). In the 24 patients with DJBL treatment >3 months (failed implantation or early removal due to side effects in 3 patients), the mean duration of implantation was 42.9 ± 13.1 weeks. During the treatment, the mean total body weight loss (%TBWL) was 15.0 ± 8.3%. Fifteen patients had long‐term follow‐up data available (mean duration of follow‐up 4.0 ± 0.9 years). The mean weight change was 12.7 ± 12.8 kg, corresponding with a mean % weight regain of 13.3 ± 13.3%. Five patients (33.3%) subsequently underwent bariatric surgery. In patients with class I obesity (BMI <35 kg/m(2) at baseline), 4 out of 6 (66.7%) had a stable weight or only a weight regain <7%. In contrast, no patient with BMI >35 kg/m(2) at baseline was able to keep weight regain below 7%. DJBL is an effective treatment for obesity, but substantial weight regain occurs during long‐term follow up after the device removal, in particular in patients with BMI > 35 kg/m(2).
format Online
Article
Text
id pubmed-10078000
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-100780002023-04-07 Sustained weight loss after duodenal–jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m(2): A retrospective cohort study Boonchaya‐anant, Patchaya Bueter, Marco Gubler, Christoph Gerber, Philipp A. Clin Obes Original Research Articles Previous data from short term studies have shown an efficacy of the duodenal‐jejunal bypass liner (DJBL) for weight loss. However, less data is available regarding weight change after device removal and possible predictors for weight loss. This is a retrospective chart review of all patients who had DJBL inserted at the University Hospital Zurich between December 2012 and June 2015. A total of 27 patients had DJBL insertion. The median BMI at baseline was 38.5 (34.0–42.2) kg/m(2). In the 24 patients with DJBL treatment >3 months (failed implantation or early removal due to side effects in 3 patients), the mean duration of implantation was 42.9 ± 13.1 weeks. During the treatment, the mean total body weight loss (%TBWL) was 15.0 ± 8.3%. Fifteen patients had long‐term follow‐up data available (mean duration of follow‐up 4.0 ± 0.9 years). The mean weight change was 12.7 ± 12.8 kg, corresponding with a mean % weight regain of 13.3 ± 13.3%. Five patients (33.3%) subsequently underwent bariatric surgery. In patients with class I obesity (BMI <35 kg/m(2) at baseline), 4 out of 6 (66.7%) had a stable weight or only a weight regain <7%. In contrast, no patient with BMI >35 kg/m(2) at baseline was able to keep weight regain below 7%. DJBL is an effective treatment for obesity, but substantial weight regain occurs during long‐term follow up after the device removal, in particular in patients with BMI > 35 kg/m(2). Blackwell Publishing Ltd 2022-10-14 2023-02 /pmc/articles/PMC10078000/ /pubmed/36239531 http://dx.doi.org/10.1111/cob.12561 Text en © 2022 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research Articles
Boonchaya‐anant, Patchaya
Bueter, Marco
Gubler, Christoph
Gerber, Philipp A.
Sustained weight loss after duodenal–jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m(2): A retrospective cohort study
title Sustained weight loss after duodenal–jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m(2): A retrospective cohort study
title_full Sustained weight loss after duodenal–jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m(2): A retrospective cohort study
title_fullStr Sustained weight loss after duodenal–jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m(2): A retrospective cohort study
title_full_unstemmed Sustained weight loss after duodenal–jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m(2): A retrospective cohort study
title_short Sustained weight loss after duodenal–jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m(2): A retrospective cohort study
title_sort sustained weight loss after duodenal–jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m(2): a retrospective cohort study
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078000/
https://www.ncbi.nlm.nih.gov/pubmed/36239531
http://dx.doi.org/10.1111/cob.12561
work_keys_str_mv AT boonchayaanantpatchaya sustainedweightlossafterduodenaljejunalbypasslinertreatmentinpatientswithbodymassindexbelowbutnotabove35kgm2aretrospectivecohortstudy
AT buetermarco sustainedweightlossafterduodenaljejunalbypasslinertreatmentinpatientswithbodymassindexbelowbutnotabove35kgm2aretrospectivecohortstudy
AT gublerchristoph sustainedweightlossafterduodenaljejunalbypasslinertreatmentinpatientswithbodymassindexbelowbutnotabove35kgm2aretrospectivecohortstudy
AT gerberphilippa sustainedweightlossafterduodenaljejunalbypasslinertreatmentinpatientswithbodymassindexbelowbutnotabove35kgm2aretrospectivecohortstudy